Chenodeoxycholic Acid (CAS 474-25-9): Complete Guide to This Primary Bile Acid for Gallstone Treatment

Introduction

Chenodeoxycholic acid (also known as chenodiol) is a primary bile acid that plays a crucial role in human metabolism and has been used medically for decades to treat cholesterol gallstones. With the CAS number 474-25-9, this compound is one of the two primary bile acids produced by the human liver and has garnered significant attention in gastroenterology for its therapeutic applications.

This comprehensive guide explores the chemical properties, mechanisms of action, clinical applications, safety considerations, and market significance of Chenodeoxycholic Acid.

What is Chenodeoxycholic Acid?

Chenodeoxycholic acid is a primary bile acid with the molecular formula C24H40O4 and a molecular weight of 392.57 g/mol. It is one of the two main primary bile acids in humans, with the other being cholic acid. Originally discovered and isolated from bird droppings (particularly from chickens and other birds), chenodeoxycholic acid is now synthesized commercially for pharmaceutical applications.

Propriétés chimiques

• CAS Number: 474-25-9
• Formule moléculaire : C24H40O4
• Molecular Weight: 392.57 g/mol
• Apparence : Poudre cristalline blanche
• Point de fusion : 165-167°C
• Solubilité : Soluble in alcohol, chloroform, and dilute alkali solutions

Classification

• Type: Primary bile acid
• Category: API (Active Pharmaceutical Ingredient) / Food Additives

Natural Sources and Biosynthesis

Chenodeoxycholic acid is synthesized in the human liver from cholesterol through a complex biochemical pathway involving multiple enzymatic reactions. The process, known as the bile acid synthesis pathway, involves approximately 17 different enzymes and represents a major route for cholesterol elimination from the body.

In nature, chenodeoxycholic acid can be found in:

• Human bile: Approximately 30-40% of total bile acid pool
• Bird droppings: Historically the main source for commercial extraction
• Animal bile: Particularly from chickens, ducks, and other poultry

Today, commercial production primarily relies on chemical synthesis to ensure purity and consistent quality for pharmaceutical applications.

Mécanisme d'action

The therapeutic action of chenodeoxycholic acid in treating cholesterol gallstones is based on its ability to reduce cholesterol saturation in bile. Here is how it works:

1. Cholesterol Reduction in Bile

Chenodeoxycholic acid acts by:

• Suppressing hepatic synthesis of cholesterol
• Reducing cholesterol secretion into bile
• Increasing the proportion of bile acids in bile

2. Gallstone Dissolution

When bile becomes unsaturated with cholesterol, existing cholesterol gallstones can gradually dissolve. The process typically requires:

• 4-24 months of continuous treatment
• Functioning gallbladder
• Radiolucent (non-calcified) cholesterol stones smaller than 20mm

3. Metabolic Effects

Beyond gallstone treatment, chenodeoxycholic acid also:

• Stimulates bile flow
• Enhances intestinal absorption of dietary fats
• Modulates gut microbiome composition

Clinical Applications and Uses

1. Primary Indication: Cholesterol Gallstone Dissolution

The main therapeutic use of chenodeoxycholic acid is for the medical treatment of cholesterol gallstones. This treatment is particularly suitable for:

• Patients with small cholesterol stones (less than 20mm in diameter)
• Patients with functioning gallbladder
• Patients who are poor candidates for surgery
• Patients refusing surgery
• As an adjunct to lithotripsy (stone-breaking procedures)

2. Cerebrotendinous Xanthomatosis (CTX)

Chenodeoxycholic acid is also used to treat cerebrotendinous xanthomatosis, a rare genetic disorder characterized by:

• Abnormal cholesterol accumulation in tendons and brain
• Neurological dysfunction
• Premature cataracts

3. Biliary Secretion Disorders

The compound is sometimes used in research and clinical settings to study bile secretion disorders and liver function.

4. Research Applications

In laboratory settings, chenodeoxycholic acid is used as:

• Cholesterol-lowering agent in research
• Standard reference compound in bile acid analysis
• Tool compound in metabolic research

Benefits and Efficacy

Gallstone Dissolution Success Rates

Clinical studies have demonstrated that chenodeoxycholic acid can achieve complete gallstone dissolution in:

• 50-60% of patients with suitable stones
• Up to 80% when combined with ursodeoxycholic acid
• Typically requires 6-24 months of treatment

Key Advantages

1. Non-invasive treatment option – Avoids surgical risks
2. Effective for small cholesterol stones
3. Can be used in high-risk patients
4. Relatively low cost compared to surgery
5. No recovery time required